Neutrolis, Inc.

Organization

Cambridge, MA, US

Organizations

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Engineering of DNASE enzymes for manufacturing and therapy
- Patent number 11,840,712
- Issue date Dec 12, 2023
- NEUTROLIS, INC.
- Tobias A. Fuchs
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Engineering of DNASE enzymes for manufacturing and therapy
- Patent number 11,578,314
- Issue date Feb 14, 2023
- NEUTROLIS, INC.
- Tobias A. Fuchs
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Methods for treating or preventing tissue adhesions
- Patent number 11,464,833
- Issue date Oct 11, 2022
- NEUTROLIS, INC.
- Michael Boettcher
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Engineered human extracellular DNASE enzymes
- Patent number 11,352,613
- Issue date Jun 7, 2022
- NEUTROLIS, INC.
- Tobias A. Fuchs
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Methods of using DNASE1-like 3 in therapy
- Patent number 11,058,724
- Issue date Jul 13, 2021
- NEUTROLIS, INC.
- Tobias A. Fuchs
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
DNase therapy for intravascular accumulation of extracellular DNA
- Patent number 11,046,943
- Issue date Jun 29, 2021
- NEUTROLIS, INC.
- Tobias A. Fuchs
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
DNase therapy for intravascular accumulation of extracellular DNA
- Patent number 11,046,942
- Issue date Jun 29, 2021
- NEUTROLIS, INC.
- Tobias A. Fuchs
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Manufacturing and engineering of DNASE enzymes for therapy
- Patent number 10,988,746
- Issue date Apr 27, 2021
- NEUTROLIS, INC.
- Tobias A. Fuchs
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Engineered DNase enzymes and use in therapy
- Patent number 10,801,019
- Issue date Oct 13, 2020
- NEUTROLIS, INC.
- Tobias A. Fuchs
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Engineered DNase enzymes and use in therapy
- Patent number 10,696,956
- Issue date Jun 30, 2020
- NEUTROLIS, INC.
- Tobias A. Fuchs
- C07 - ORGANIC CHEMISTRY

Please log in for detailed analytics

Patents Applicationslast 30 patents

Information Patent Application
ENGINEERED HUMAN EXTRACELLULAR DNASE ENZYMES
- Publication number 20250129347
- Publication date Apr 24, 2025
- Neutrolis, Inc.
- Tobias A. FUCHS
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
DNASE ENZYMES ENGINEERED FOR IMPROVED STABILITY
- Publication number 20240401015
- Publication date Dec 5, 2024
- Neutrolis, Inc.
- Toby Fox
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
DNASE1-LIKE 3 AND ITS USE IN THERAPY
- Publication number 20240374643
- Publication date Nov 14, 2024
- Neutrolis, Inc.
- Tobias A. FUCHS
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ENGINEERED HUMAN EXTRACELLULAR DNASE ENZYMES FOR DRUG CANDIDATE SEL...
- Publication number 20240368569
- Publication date Nov 7, 2024
- Neutrolis, Inc.
- Tobias A. FUCHS
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
DNASE 1-LIKE 2 ENGINEERED FOR MANUFACTURING AND USE IN THERAPY
- Publication number 20240228995
- Publication date Jul 11, 2024
- Neutrolis, Inc.
- Tobias A. FUCHS
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ENGINEERING OF DNASE ENZYMES FOR MANUFACTURING AND THERAPY
- Publication number 20240191218
- Publication date Jun 13, 2024
- Neutrolis, Inc.
- Tobias A. FUCHS
- C07 - ORGANIC CHEMISTRY
Information Patent Application
DNASE 1-LIKE 2 ENGINEERED FOR MANUFACTURING AND USE IN THERAPY
- Publication number 20240132863
- Publication date Apr 25, 2024
- Neutrolis, Inc.
- Tobias A. FUCHS
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
METHODS FOR TREATING OR PREVENTING TISSUE ADHESIONS
- Publication number 20230302097
- Publication date Sep 28, 2023
- Neutrolis, Inc.
- Michael BOETTCHER
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
BASIC DOMAIN-DELETED DNASE1-LIKE 3 AND USES THEREOF
- Publication number 20230072226
- Publication date Mar 9, 2023
- Neutrolis, Inc.
- Tobias A. FOX
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ENGINEERED HUMAN EXTRACELLULAR DNASE ENZYMES
- Publication number 20220259579
- Publication date Aug 18, 2022
- Neutrolis, Inc.
- Tobias A. FUCHS
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ENGINEERING OF DNASE ENZYMES FOR MANUFACTURING AND THERAPY
- Publication number 20220162575
- Publication date May 26, 2022
- Neutrolis, Inc.
- Tobias A. FUCHS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANIMAL MODEL FOR DRUG DEVELOPMENT
- Publication number 20220132817
- Publication date May 5, 2022
- Neutrolis, Inc.
- Tobias FUCHS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ENGINEERED HUMAN EXTRACELLULAR DNASE ENZYMES
- Publication number 20220042002
- Publication date Feb 10, 2022
- Neutrolis, Inc.
- Tobias A. FUCHS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ENGINEERED HUMAN EXTRACELLULAR DNASE ENZYMES FOR DRUG CANDIDATE SEL...
- Publication number 20220025343
- Publication date Jan 27, 2022
- Neutrolis, Inc.
- Tobias A. FUCHS
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS OF USING DNASE1-LIKE 3 IN THERAPY
- Publication number 20210299178
- Publication date Sep 30, 2021
- Neutrolis, Inc.
- Tobias A. FUCHS
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ENGINEERED DNASE ENZYMES AND USE IN THERAPY
- Publication number 20210277372
- Publication date Sep 9, 2021
- Neutrolis, Inc.
- Tobias A. FUCHS
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ENGINEERING OF DNASE ENZYMES FOR MANUFACTURING AND THERAPY
- Publication number 20210207114
- Publication date Jul 8, 2021
- Neutrolis, Inc.
- Tobias A. FUCHS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
DNASE THERAPY FOR INTRAVASCULAR ACCUMULATION OF EXTRACELLULAR DNA
- Publication number 20210040461
- Publication date Feb 11, 2021
- Neutrolis, Inc.
- Tobias A. FUCHS
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ENGINEERED DNASE ENZYMES AND USE IN THERAPY
- Publication number 20200399622
- Publication date Dec 24, 2020
- Neutrolis, Inc.
- Tobias A. FUCHS
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ENGINEERED DNASE ENZYMES AND USE IN THERAPY
- Publication number 20200347370
- Publication date Nov 5, 2020
- Neutrolis, Inc.
- Tobias A. FUCHS
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
DNASE1-LIKE 3 AND ITS USE IN THERAPY
- Publication number 20200323917
- Publication date Oct 15, 2020
- Neutrolis, Inc.
- Tobias A. FUCHS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MANUFACTURING AND ENGINEERING OF DNASE ENZYMES FOR THERAPY
- Publication number 20200115690
- Publication date Apr 16, 2020
- Neutrolis, Inc.
- Tobias A. FUCHS
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ENGINEERED DNASE ENZYMES AND USE IN THERAPY
- Publication number 20200024585
- Publication date Jan 23, 2020
- Neutrolis, Inc.
- Tobias A. FUCHS
- C07 - ORGANIC CHEMISTRY

Please log in for detailed analytics

Trademarklast 30 trademarks

Information Trademark
88669573 - NEUTROLIS
- Serial number 88669573
- Registration number 6058743
- Filing date Oct 25, 2019
- Neutrolis, Inc.
- 5 - Pharmaceutical and veterinary preparations

NIH Research Projectlast 12 months

processing...

Count: 1

Research Projects

Information Research Project
Genetic profiling of SLE patients with impaired NET degradation.
- Application id 10010568
- Award notice date Apr 24, 2020

Neutrolis, Inc.

Organization

Patents Grantslast 30 patents

Engineering of DNASE enzymes for manufacturing and therapy

Engineering of DNASE enzymes for manufacturing and therapy

Methods for treating or preventing tissue adhesions

Engineered human extracellular DNASE enzymes

Methods of using DNASE1-like 3 in therapy

DNase therapy for intravascular accumulation of extracellular DNA

DNase therapy for intravascular accumulation of extracellular DNA

Manufacturing and engineering of DNASE enzymes for therapy

Engineered DNase enzymes and use in therapy

Engineered DNase enzymes and use in therapy

Patents Applicationslast 30 patents

ENGINEERED HUMAN EXTRACELLULAR DNASE ENZYMES

DNASE ENZYMES ENGINEERED FOR IMPROVED STABILITY

DNASE1-LIKE 3 AND ITS USE IN THERAPY

ENGINEERED HUMAN EXTRACELLULAR DNASE ENZYMES FOR DRUG CANDIDATE SEL...

DNASE 1-LIKE 2 ENGINEERED FOR MANUFACTURING AND USE IN THERAPY

ENGINEERING OF DNASE ENZYMES FOR MANUFACTURING AND THERAPY

DNASE 1-LIKE 2 ENGINEERED FOR MANUFACTURING AND USE IN THERAPY

METHODS FOR TREATING OR PREVENTING TISSUE ADHESIONS

BASIC DOMAIN-DELETED DNASE1-LIKE 3 AND USES THEREOF

ENGINEERED HUMAN EXTRACELLULAR DNASE ENZYMES

ENGINEERING OF DNASE ENZYMES FOR MANUFACTURING AND THERAPY

ANIMAL MODEL FOR DRUG DEVELOPMENT

ENGINEERED HUMAN EXTRACELLULAR DNASE ENZYMES

ENGINEERED HUMAN EXTRACELLULAR DNASE ENZYMES FOR DRUG CANDIDATE SEL...

METHODS OF USING DNASE1-LIKE 3 IN THERAPY

ENGINEERED DNASE ENZYMES AND USE IN THERAPY

ENGINEERING OF DNASE ENZYMES FOR MANUFACTURING AND THERAPY

DNASE THERAPY FOR INTRAVASCULAR ACCUMULATION OF EXTRACELLULAR DNA

ENGINEERED DNASE ENZYMES AND USE IN THERAPY

ENGINEERED DNASE ENZYMES AND USE IN THERAPY

DNASE1-LIKE 3 AND ITS USE IN THERAPY

MANUFACTURING AND ENGINEERING OF DNASE ENZYMES FOR THERAPY

ENGINEERED DNASE ENZYMES AND USE IN THERAPY

Trademarklast 30 trademarks

88669573 - NEUTROLIS

NIH Research Projectlast 12 months

Research Projects

Genetic profiling of SLE patients with impaired NET degradation.